Whether the platelet aggregation rate of 90.1% in pregnant women can be treated or not should be judged according to the development of the fetus, the fetus is not yet abnormal can be treated, need to take antiplatelet drugs under the guidance of the doctor, such as low molecular heparin; due to the high platelet aggregation rate triggered by miscarriage, fetal arrest, then there is no need for treatment, and need to be terminated in time to deal with the pregnancy.
Platelet aggregation rate reflects the aggregation function of platelets, clinically the normal value of platelet aggregation rate is 55%-90%, most of the people in the 70% or so, pregnant women platelet aggregation rate of 90% belongs to the normal range, pregnant women platelet aggregation rate of 90.1% is a little higher.
Pregnant women platelet aggregation rate 90.1% on the growth and development of the baby has not yet caused an impact, due to the condition of the patient, under the guidance of the doctor to take antiplatelet drugs, such as low molecular heparin treatment.
Increased platelet aggregation rate during pregnancy is prone to thrombosis, which may cause capillary thrombosis in early pregnancy, affecting embryonic development and causing miscarriage in severe cases. High platelet aggregation rate in mid to late pregnancy leads to insufficient blood supply to the fetus, affecting the development of the fetus will cause intrauterine stillbirth, there is no need to go to the treatment of miscarriage or abortion has occurred, timely treatment through the clearance of the uterus surgery.
Platelet aggregation rate of 90.1% in pregnant women, it is recommended that targeted treatment under the guidance of a doctor.